CGO Group Support Foreign Investors in Adapting to Polish Tax and Accounting Regulations

CGO Legal has provided, over the years, legal support to more than 1500 Polish companies, mostly with a foreign ownership structure. The team consists of over 50 qualified experts, specializing in legal, taxation, and accounting fields. They support a new category of clients on the Polish legal... - December 06, 2022 - CGO Legal Chajdas Gawlak Owczarek sp. k.

PharmStars Announces “Innovations in Women’s Health and Health Equity” Theme for Spring 2023 Accelerator

PharmStars Announces “Innovations in Women’s Health and Health Equity” Theme for Spring 2023 Accelerator

PharmStars, the pharma-focused accelerator for digital health startups, is now accepting applications for its Spring 2023 cohort with the theme “Digital Innovations in Women’s Health and Health Equity.” Startups with digital innovations that promote more equitable, inclusive healthcare for underserved population or focused on women’s health (e.g., breast, ovarian, and cervical cancer; gynecological conditions; osteoporosis; menopausal, hormonal, and reproductive conditions) are welcome to apply. - December 05, 2022 - PharmStars

Clinical Research Organization, Huntington Study Group “Firsts” Continue

Clinical Research Organization, Huntington Study Group “Firsts” Continue

The Huntington Study Group (HSG), a world leader in conducting clinical trials for Huntington’s Disease (HD) through its Clinical Research Organization (CRO), HSG Clinical Research, Inc. (HSGCR) continues making groundbreaking progress in the HD world. At their Annual Meeting in November, the... - December 05, 2022 - Huntington Study Group

Paras Biopharmaceuticals Finland Oy is Highly Recommended for Biologics CDMO – Development / Scale-up & Production of Biologics by Innovative USA Biopharma Company

Paras Biopharmaceuticals is pleased to announce that the company has been highly recommended for its Biologics CDMO – development / scale-up and production capabilities. The Paras Biopharmaceuticals Team has successfully completed multiple biologics projects in 2022. - November 29, 2022 - Paras Biopharmaceuticals Finland Oy

Huntington Study Group Annual Meeting

Huntington Study Group Annual Meeting

The Huntington Study Group (HSG), a world leader in conducting clinical trials for Huntington’s Disease (HD), recently held its 29th Annual Meeting in Tampa, FL. This renowned meeting brings together HD thought leaders, scientific experts, industry partners and sponsors, advocacy groups, and... - November 29, 2022 - Huntington Study Group

Creative Diagnostics Introduces Hemagglutination Assay Service for Scientific Applications

Creative Diagnostics recently introduced Hemagglutination Assay services for influenza vaccine, diagnostic, and surveillance communities to measure virus and antibody titers and monitor influenza subtypes. - November 26, 2022 - Creative Diagnostics

Creative Diagnostics Announces New Polyethylene Glycol Antibodies Detection Kits

Creative Diagnostics announced the launch of a panel of anti-PEG IgG or IgM ELISA kits with different species reactivity to detect anti-PEG IgG or IgM in serum and plasma. - November 26, 2022 - Creative Diagnostics

Marty Rosenberg joins the Board of Scientific Advisors at Microvascular Therapeutics.

Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, Arizona, announced the appointment of Marty Rosenberg to the MVT Board of Scientific Advisors. Mr. Rosenberg brings a broad experience with the clinical development and global regulatory approval process for... - November 25, 2022 - Microvascular Therapeutics, Inc.

David Lim Joins the Team at Microvascular Therapeutics as Director of Finance

Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, Arizona, announced the appointment of David Lim as Director of Finance at MVT. Mr. Lim brings a broad experience with the business development and strategic financing for diagnostic pharmaceuticals across all... - November 25, 2022 - Microvascular Therapeutics, Inc.

Morgan County Medical Oncology Practices Combine to Provide Comprehensive Cancer Care

Morgan County Medical Oncology Practices Combine to Provide Comprehensive Cancer Care

Cancer Care Center of Decatur is joining Clearview Cancer Institute. CCI welcomes Dr. Naveen Lobo. - November 23, 2022 - Clearview Cancer Institute

Novugen Pharma Became the First Pharmaceutical Company in Malaysia to Receive USFDA Approval for Its Manufacturing Facility

Novugen Pharma Became the First Pharmaceutical Company in Malaysia to Receive USFDA Approval for Its Manufacturing Facility

The Company was audited in September 2022 and USFDA issued an Establishment Inspection Report (EIR) in November 2022. Novugen Pharma is the first USFDA approved pharmaceutical manufacturing in Malaysia and the only in Southeast Asia. - November 22, 2022 - Novugen

Introducing MIRAPeel MD, the Only 6-in-1 Clinical-Grade Skincare Platform of Its Kind

Introducing MIRAPeel MD, the Only 6-in-1 Clinical-Grade Skincare Platform of Its Kind

Attention Dermatologists, Plastic Surgeons and Med Spa Owners: Meet MIRAPeel MD, the one stop shop for all skin needs, and the first of its kind. Offering 6 treatments in one, MIRAPeel MD is setting a new treatment standard for skin care specialists, medical spas, dermatology and plastic surgery offices. - November 22, 2022 - eMIRAmed

iSpring Solutions Inc. Updates Its Range of Stand-Alone Tools to Version 11

iSpring Solutions Inc. Updates Its Range of Stand-Alone Tools to Version 11 and launches special offers on iSpring QuizMaker, iSpring Presenter, iSpring Converter Pro, and other powerful eLearning tools. - November 21, 2022 - iSpring Solutions Inc.

Immunodominant Announces Call for Initial Investment Round as Company Prepares for Phase 2 Study of Oral OTC COVID-19 Drug

Immunodominant Inc., a drug discovery and development company engaged in progressing innovative research from academia to commercialization, today announced its intention to begin an initial financing round of up to $30 million. Immunodominant also announced today that it is scheduling a Phase 2 clinical study after a pre-IND meeting with the FDA for LACTOVID, a novel, oral, over-the-counter drug for the prevention and treatment of COVID-19. - November 20, 2022 - Immunodominant

Microvascular Therapeutics Receives Funds from the National Cancer Institute (NCI) for Its Brain Tumor Program

Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, AZ, was recently awarded a Phase I Small Business Innovation Research grant from the National Cancer Institute (NCI). Emmanuelle Meuillet, Chief Scientific and Operating Officer at MVT said, “We are... - November 18, 2022 - Microvascular Therapeutics, Inc.

Shoals Medical Oncology Practices Combine

Shoals Medical Oncology Practices Combine

Clearview Cancer Institute (CCI) and the medical oncology division of North Alabama Cancer Center (NACC), formerly Northwest Alabama Cancer Care, are joining together in Florence and Muscle Shoals, Alabama. - November 17, 2022 - Clearview Cancer Institute

Prosel Bioscience Becomes One Cell Foods and Names Dr. Scott Jenkins Its New CEO

Prosel Bioscience Becomes One Cell Foods and Names Dr. Scott Jenkins Its New CEO

One Cell Food, Inc will focus on scaling its proprietary bioreactor design to commercialize developed strains for its first food product by early 2023. As the new CEO, Dr. Scott Jenkins will lead the operation and fundraising efforts. - November 17, 2022 - One Cell Foods, Inc.

Pregmune Joins Digital Twin Consortium

Pregmune is thrilled to announce that has recently joined the Digital Twin Consortium (DTC), a global initiative created with the goal to be The Authority in Digital Twin(TM) as it relates to policy, security, interoperability, and overall development of digital twins. Founded in 2020 by Dr. - November 17, 2022 - Pregmune

Virb Lands Contract with $10B Life Sciences Company

Virb Lands Contract with $10B Life Sciences Company

Begins Series A Financing to Accelerate Growth in the Clinical Research Industry. - November 16, 2022 - Virb

Families of World War II Veterans Holds 2022 Fundraising Golf Tournament

Families of World War II Veterans held its annual golf tournament and fundraising event on Monday, October 24, at the award-winning Trinity Forest Golf Club in Dallas, Texas, the former home of the renowned AT&T Byron Nelson tournament. This is the organization’s biggest fundraising event... - November 12, 2022 - Careington

Are You Ready to Get Shroomed?

Are You Ready to Get Shroomed?

After a historical win for the war on drugs in Colorado, the state and the nation begins to look at ways to implement Magic Mushroom assisted therapy along with other plant medicine. We look at the facts behind this, and what it means for you. - November 11, 2022 - shroomed

DataJoint Launches New Cloud-Based System for Automating Neuroscience Experiments

DataJoint Launches New Cloud-Based System for Automating Neuroscience Experiments

DataJoint's New Cloud Solution Improves Lab Efficiency and Accuracy - November 11, 2022 - DataJoint

WebShield Unveils EasyAccess Rewards, EasyAccess Health, and EasyAccess Funding Enabled by a Self-Funding Privacy Network Exchange

WebShield Unveils EasyAccess Rewards, EasyAccess Health, and EasyAccess Funding Enabled by a Self-Funding Privacy Network Exchange

WebShield announces the EasyAccess Network offering identity verification, consent, enrollment, and access for Personal Privacy Network services including EasyAccess Health, EasyAccess Rewards and EasyAccess Funding. These are enabled by the Privacy Network Exchange, Quantum Privacy & Proof of Trust, and allow data, digital content, software, infrastructure, contractual rights, online engagement & brands to be safely combined and re-used with unprecedented privacy, personalization & compliance. - November 11, 2022 - WebShield, Inc.

PharmStars Announces Fall 2022 Startup Showcase Event

PharmStars Announces Fall 2022 Startup Showcase Event

PharmStars, the pharma-focused accelerator for digital health startups, announces that its Fall 2022 Showcase Event will begin on November 8, 2022. The Showcase is the culmination of a 10-week startup accelerator program. At the Showcase Event, startups will make formal presentations to and meet... - November 08, 2022 - PharmStars

Nominations Open for the Annual “Athenix Gives Back” Program

Nominations Open for the Annual “Athenix Gives Back” Program

Athenix Body Sculpting Institute invites the public to nominate an Unsung Hero to receive a complimentary cosmetic procedure of their choosing. - November 07, 2022 - Athenix Body Sculpting Institute

Biomed Industries, Inc. (“Biomed”) Today Announced the Closing of Its Merger with MedAware Systems, Inc., (“MedAware”)

Biomed Industries, Inc. (“Biomed”) today announced the closing of its merger with MedAware Systems, Inc., (“MedAware”), in which all issued and outstanding common shares of capital stock of MedAware will be exchanged for common stock of Biomed at a ratio of 5.33 shares of MedAware for 1 new common share of Biomed. The transaction valued at an aggregate of $20 million, to be paid by 2,259,170 common shares of Biomed. At present, Biomed has approximately 76,354,075 common shares issued. - November 07, 2022 - Biomed Industries, Inc.

Thrivous Launches Vitality Geroprotector Formula 2

Thrivous, the human enhancement company, has released Vitality Geroprotector Formula 2 with Mirtoselect® Blueberry Anthocyanin. Vitality is the advanced geroprotector supplement that Thrivous develops to enhance metabolism and cell function for better aging. Vitality combines geroprotector... - November 07, 2022 - Thrivous

The In-Person IPAC2022NV & Teach1Serve10 Free Clinic Days Are Postponed Due to Exemption Delays, Unforeseen Circumstances & Unpredicted Charges. Stay Tuned.

The In-Person IPAC2022NV & Teach1Serve10 Free Clinic Days Are Postponed Due to Exemption Delays, Unforeseen Circumstances & Unpredicted Charges. Stay Tuned.

The Integrative Providers Association and the Compassion Center postpone their disruptive clinical incubation, Teach1Serve10 Free Clinic Day, and the In-Person Companion Medical Conference (IPAC2022NV) due to delays in exemptions, circumstances beyond their control and unpredicted charges that continue to grow. As such, the Boards have decided to postpone the in-person conference, live-stream the education and move the free clinic day off-site to an established neighborhood clinic system. - November 04, 2022 - Integrative Providers Association

New Pivotal Data Demonstrates Clinical Feasibility of GeneFluidics’ Direct-from-Specimen AST in Clinical Settings

New Pivotal Data Demonstrates Clinical Feasibility of GeneFluidics’ Direct-from-Specimen AST in Clinical Settings

GeneFluidics, Inc. is pleased to announce a joint publication with the Medical College of Wisconsin (MCW) that introduces rapid antimicrobial susceptibility testing (AST), which would represent a paradigm shift in the clinical management of microbial infections. The data from the MCW study have... - November 04, 2022 - GeneFluidics Inc.

Thaddeus Medical Customizable Cold-Chain iQ-Ler Now Available for Pre-Order

Thaddeus Medical Customizable Cold-Chain iQ-Ler Now Available for Pre-Order

Cold Chain system is designed for storage, transportation and dispensary of temperature-sensitive medical therapeutics to eliminate all spoilage in cold-chain logistics and improve patient outcomes - November 03, 2022 - Thaddeus Medical

Pharma/Vaccine Exec Brad Thompson Joins Fuld & Company as Advisory Board Member

Pharma/Vaccine Exec Brad Thompson Joins Fuld & Company as Advisory Board Member

Fuld & Company welcomes Pharma/Vaccine Exec Brad Thompson as an Advisory Board Member. Brad brings over twenty years of experience building franchise and brand strategies in the vaccine and pharmaceutical space. He will be an instrumental member of Fuld's HLS team to help propel the success of the company's pharma and biotech clients. - November 03, 2022 - Fuld & Company

National Minority Quality Forum’s Cancer Stage Shifting Initiative Launches Website Exploring the Future of Multi-Cancer Early Detection & Equitable Cancer Care

National Minority Quality Forum’s Cancer Stage Shifting Initiative Launches Website Exploring the Future of Multi-Cancer Early Detection & Equitable Cancer Care

Exact Sciences and National Minority Quality Forum are leading the new #ShiftCancer initiative in support of the Cancer Moonshot Program. - November 02, 2022 - National Minority Quality Forum

DistillerSR Launches New CuratorCR Capabilities to More Dynamically Manage and Reuse Evidence-Based Research

CuratorCR Knowledge Center Provides Alternative to Elsevier’s QUOSA Virtual Library as Its Sunset Date Looms. - October 31, 2022 - DistillerSR

CancerLife Announces a New Platform to Address Disparities of Care with Breast Cancer

CancerLife announces the results of a clinical trial where QoL was raised by 14.3% across all care settings, which proves it solution can address disparities of care. - October 29, 2022 - CancerLife

Gallant Announces Hiring of John Klacking, Ph.D. as Chief Business Officer

Furthering its regenerative medicine therapeutics research and development, animal biotech company Gallant welcomes a pioneer in the biotech space. - October 25, 2022 - Gallant

Huntington Study Group Announces Results from the HD-Net Assessment on the State of Care for Huntington’s Disease in the United States

Huntington Study Group Announces Results from the HD-Net Assessment on the State of Care for Huntington’s Disease in the United States

The Huntington Study Group (HSG), a world leader in clinical research for Huntington’s Disease (HD) for over 30 years, is pleased to announce the results from the novel HD-Net survey, which examined the United States Huntington’s disease (HD) care delivery in a variety of clinic settings by HD specialists and non-specialists. - October 25, 2022 - Huntington Study Group

Minus K Technology Announces Announces Its Seventh U.S. Educational Giveaway of Vibration Isolators to Colleges and Universities

As Minus K celebrates their upcoming 30 years in business, they are giving away $25,000* dollars worth of passive mechanical patented superior performing negative-stiffness low-frequency vibration isolators to colleges in the United States. - October 25, 2022 - Minus K Technology Inc.

Vivisum Partners Publishes Strategic Analysis on the Ulcerative Colitis Marketplace

Among branded ulcerative colitis treatments, 84% of US gastroenterologists expect Zeposia to see an increase in prescription volume over the next 12 months, according to new research on the ulcerative colitis marketplace published by Vivisum Partners. Vivisum Partners has just published its... - October 25, 2022 - Vivisum Partners, LLC

New Market Insights on the Best MS Treatment Published by Vivisum Partners

What’s the best MS treatment according to neurologists? The question of how to assess the ideal drug to treat multiple sclerosis is difficult to answer. Neurologists determine which clinical attributes take higher priority for each patient. Vivisum Partners, LLC, a market research firm in... - October 24, 2022 - Vivisum Partners, LLC

Creative Diagnostics Introduces Fluorometric Neuraminidase Assay Service for High-Throughput Discovery

As an expert in the antiviral field providing solutions to assist virology and microbiology research, Creative Diagnostics recently introduced Fluorometric Neuraminidase Assay services to the global research community, suitable for functional detection of NI-resistant viruses in mixed virus... - October 23, 2022 - Creative Diagnostics

Creative Diagnostics Launches Monkeypox Virus Antigens and Antibodies to Accelerate MPXV Study

Creative Diagnostics announced the launch of Monkeypox Virus Antigens and Antibodies to support scientists focused on the research of monkeypox virus. - October 23, 2022 - Creative Diagnostics

ARA Breast Radiologist Goes All Pink to Emphasize Importance of Mammography

ARA Breast Radiologist Goes All Pink to Emphasize Importance of Mammography

It’s Breast Cancer Awareness Month and many are working to bring attention to breast cancer and the importance of screening with mammography. However, Dr. Arthy Saravanan, head of the breast imaging section at ARA Diagnostic Imaging, is going the extra mile, in a bright pink car. Dr. - October 18, 2022 - ARA Diagnostic Imaging

Huntington Study Group Announces myHDstory™ Pilot Study: Making HD Voices Heard Has Reached Target Enrollment

Huntington Study Group Announces myHDstory™ Pilot Study: Making HD Voices Heard Has Reached Target Enrollment

The Huntington Study Group (HSG), a world leader in clinical research for Huntington’s Disease (HD) for over 30 years, is pleased to announce that the pilot study, Making HD Voices Heard, on the new online research platform, myHDstory™, has reached its enrollment target. “The HSG... - October 18, 2022 - Huntington Study Group

Kantify and Mcule Harness the Power of Data to Accelerate Drug Discovery

Kantify and Mcule Harness the Power of Data to Accelerate Drug Discovery

Kantify, using its AI technology for drug discovery and Mcule, with its compound sourcing platform, are collaborating to leverage data for better hit prediction. - October 17, 2022 - Mcule

Biolexis Therapeutics Announces Launch of FIELDS, an AI/ML Drug Discovery Platform

Biolexis is the first company to combine a curated historical wet-lab database, including half-a-million targets of binding data points, with an automated AI/ML-augmented discovery platform. - October 14, 2022 - Biolexis Therapeutics Inc.

Thrivous Releases Serenity Nightly Nootropic Formula 3

Thrivous, the human enhancement company, has released Serenity Nightly Nootropic Formula 3 with KSM-66® Ashwagandha. Serenity is the advanced nootropic supplement that Thrivous develops to enhance relaxation, sleep, and next-day focus. Serenity combines nootropic nutrients with the highest... - October 14, 2022 - Thrivous

Keva Health to Reveal New Study Results at CHEST Conference

Keva Health to Reveal New Study Results at CHEST Conference

Keva Health, Baystate Health and UMass Medical School selected for 2 oral presentations at premier CHEST conference on Oct. 16-19 in Nashville, Tennessee. Exciting data observed in a cohort study at Baystate Health pulmonology center showing patient engagement and prevention of hospitalizations. - October 13, 2022 - Keva Health

Huntington Study Group Enrolls First Participant for Its Observational Study to Test the Reliability of the Virtual Use of the Unified Huntington’s Disease Rating Scale

Huntington Study Group Enrolls First Participant for Its Observational Study to Test the Reliability of the Virtual Use of the Unified Huntington’s Disease Rating Scale

The Huntington Study Group (HSG), a world leader in conducting clinical trials for Huntington’s Disease (HD) for over 30 years, together with its Clinical Research Organization (“CRO”), the HSG Clinical Research, Inc., today announces the enrollment of the first participant of its... - October 12, 2022 - Huntington Study Group

Mirror Biologics, Inc. Announces Additional $20 Million Investment to Close Out $30 Million Series A Investment Round

Mirror Biologics, Inc. Announces Additional $20 Million Investment to Close Out $30 Million Series A Investment Round

Mirror Biologics, Inc., a clinical stage biopharmaceutical company today announced the completion of the final $20 million tranche of its $30 million Series A investment round with Bradbury Asset Management (Hong Kong), Limited. Bradbury provided an initial $10 million tranche for this round in... - October 11, 2022 - Mirror Biologics, Inc.

SYNG Pharmaceuticals Announces Issuance of Its Canadian Patent for Non-Hormonal Therapy for Endometriosis

SYNG Pharmaceuticals Inc. (SYNG), a Kingston, Ontario based women’s health biotech, is pleased to announce that on October 04, 2022, the Canadian Intellectual Property Office granted Canada Patent No. 2,903,608 titled, "Treatment of endometriosis, angiogenesis and/or endometrial lesion growth." - October 09, 2022 - SYNG Pharmaceuticals Inc.

Press Releases 251 - 300 of 8,593